The Resource Trade-Off

What Are You Willing to Stop Funding?

The most revealing question in strategy may not be what you will fund next. It may be what you are willing to stop funding.

Most healthcare strategy conversations ask:

What should we invest in?

Very few ask:

What should we stop investing in?

That distinction matters.

Every strategic commitment consumes something:

• Capital

• Talent

• Leadership attention

• Technology capacity

• Organizational bandwidth

• Management capability

Therefore, every new strategic priority implicitly creates a trade-off.

If nothing is displaced, the organization may not have created a priority at all. It may simply have added another commitment to an already-funded portfolio.

Strategy Is Not Only About Addition

Healthcare organizations routinely add.

A new service line.

A new location.

A digital platform.

A physician recruitment initiative.

An AI program.

An acquisition.

A transformation project.

Each may have a legitimate strategic rationale.

But the harder executive question is:

What becomes harder to fund because we chose this?

This is the overlooked side of strategy.

Resource allocation is not merely a financial exercise. It determines which capabilities an organization can build, which opportunities it can pursue, and which businesses receive the organizational oxygen to develop.

McKinsey has repeatedly identified resource reallocation as an important component of long-term value creation, noting that many organizations allow historical allocations to persist rather than dynamically shifting resources toward changing opportunities. More recent McKinsey research similarly emphasizes moving beyond incremental budgeting and reallocating resources toward future growth.

The Comfort of Continuing to Fund

Stopping something is psychologically and organizationally different from approving something new.

An existing initiative already has:

• people attached to it,

• historical justification,

• established budgets,

• internal advocates,

• performance data,

• and often an executive sponsor.

That creates a powerful form of institutional inertia.

The question becomes less:

“Does this deserve resources today?”

and more:

“Can we justify taking resources away?”

That is a very different decision.

Harvard Business Review has highlighted the difficulty organizations face in deciding when a strategic project is no longer worth its resource investment. The challenge is not simply recognizing poor performance; it is overcoming the consequences of continuing to invest after the strategic case has weakened.

The Provocative Question: What Are You Protecting?

Consider four questions:

What are we continuing to fund because stopping would be uncomfortable?

Which initiative would we not approve today if we were evaluating it from scratch?

What deserves less funding so something more strategically important can receive more?

What are we protecting because of history rather than future value?

These questions are uncomfortable because they challenge the assumption that yesterday's allocation deserves tomorrow's resources.

A successful service line may continue receiving investment simply because it has always performed.

A mature location may continue consuming leadership attention because it is familiar.

A legacy technology platform may continue receiving funding because changing it feels disruptive.

An initiative may remain alive because nobody wants to own the decision to stop it.

None of these automatically means the investment is wrong.

But none should be protected from re-evaluation simply because it already exists.

Resource Trade-Off™: The Missing Side of Strategy

Phoenix MedStrategy defines Resource Trade-Off™ as:

The deliberate recognition that every strategic investment requires the organization to surrender resources that could otherwise support another opportunity.

This creates a different way to evaluate strategic decisions.

Instead of asking only:

“What will this initiative create?”

ask:

“What will this initiative displace?”

That displacement might be financial.

But it could also involve a scarce physician, a senior executive's time, technology capacity, implementation capability, management bandwidth, or the organization's ability to absorb another transformation.

This is why two individually attractive initiatives can become collectively unattractive.

Both may have positive business cases.

But the organization may not have enough strategic capacity to fund both effectively.

If Everything Remains Funded, Has Anything Become a Priority?

This is perhaps the most provocative test.

If everything remains funded, has anything actually become a strategic priority?

Real prioritization creates asymmetry.

More resources move toward something.

Less resources remain available elsewhere.

That does not necessarily mean shutting down successful businesses or abandoning important capabilities. It means acknowledging that strategic choice requires differential allocation.

McKinsey research on portfolio strategy similarly emphasizes dynamic resource reallocation and identifying areas where organizations may need to cut back or divest rather than simply adding new growth initiatives.

The Executive Test

Before approving the next major strategic commitment, ask five questions:

1. What value are we trying to create?

2. What resources will this require?

3. What currently receives those resources?

4. What becomes harder to fund because of this decision?

5. If we were starting from zero today, would we still fund the existing commitment?

The objective is not to become conservative.

It is to make trade-offs visible.

Because strategy is ultimately revealed not by what leadership says matters—but by where the organization continues to put its resources.

The Phoenix Perspective

Healthcare leaders do not have unlimited capital, talent, technology capacity, or organizational bandwidth.

Every “yes” has an economic and strategic “not now” attached to it.

The organizations that recognize this do not simply ask where to invest next.

They continuously examine what no longer deserves the same level of investment—and deliberately release resources for what matters more to the future.

The strategic question is no longer simply: “What should we fund?”

It is: “What are we willing to stop funding so the future has room to grow?”

Sources

McKinsey & Company, “Where to compete in today’s healthcare market”; “Tying short-term decisions to long-term strategy,” 2024.

Harvard Business Review, “How to Know When to Stop a Strategic Project,” 2025.

McKinsey & Company, “Portfolio Strategy.”